Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Reiffel, JA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 38 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Reiffel, JA
      Issues in the use of generic antiarrhythmic drugs

      CURRENT OPINION IN CARDIOLOGY
    2. Page, RL; Reiffel, JA; Tavel, ME
      Asymptomatic atrial fibrillation - Problems of management

      CHEST
    3. Reiffel, JA
      Inpatient versus outpatient antiarrhythmic drug initiation: safety and cost-effectiveness issues

      CURRENT OPINION IN CARDIOLOGY
    4. Reiffel, JA; Kowey, PR
      Generic antiarrhythmics are not therapeutically equivalent for the treatment of tachyarrhythmias

      AMERICAN JOURNAL OF CARDIOLOGY
    5. Reiffel, JA
      Drug choices in the treatment of atrial fibrillation

      AMERICAN JOURNAL OF CARDIOLOGY
    6. Reiffel, JA
      Formulation substitution and other pharmacokinetic variability: Underappreciated variables affecting antiarrhythmic efficacy and safety in clinical practice

      AMERICAN JOURNAL OF CARDIOLOGY
    7. Exner, DV; Reiffel, JA; Epstein, AE; Ledingham, R; Reiter, MJ; Yao, Q; Duff, HJ; Follmann, D; Schron, E; Greene, HL; Carlson, MD; Brodsky, MA; Akiyama, T; Baessler, C; Anderson, JL
      Beta-blocker use and survival in patients with ventricular fibrillation orsymptomatic ventricular tachycardia: The Antiarrhythmics Versus Implantable Defibrillators (AVID) trial

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    8. Reiffel, JA
      Predictability of response rates, efficacy, risks, and intolerance with sotalol when used for sustained ventricular arrhythmias

      AMERICAN HEART JOURNAL
    9. KASSOTIS J; COSTEAS C; BLITZER M; REIFFEL JA
      RHYTHM MANAGEMENT IN ATRIAL-FIBRILLATION - WITH A PRIMARY EMPHASIS ONPHARMACOLOGICAL THERAPY - PART 3

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    10. COSTEAS C; KASSOTIS J; BLITZER M; REIFFEL JA
      RHYTHM MANAGEMENT IN ATRIAL-FIBRILLATION - WITH A PRIMARY EMPHASIS ONPHARMACOLOGICAL THERAPY - PART 2

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    11. BLITZER M; COSTEAS C; KASSOTIS J; REIFFEL JA
      RHYTHM MANAGEMENT IN ATRIAL-FIBRILLATION - WITH A PRIMARY EMPHASIS ONPHARMACOLOGICAL THERAPY - PART 1

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    12. EXNER DV; EPSTEIN AE; REITER MJ; YAO Q; LEDINGHAM R; REIFFEL JA; BRODSKY M; AKIYAMA T; SCHRON E; FOLLMANN D; ANDERSON J
      BETA-BLOCKER USE AND MORTALITY IN THE ANTIARRHYTHMICS VERSUS IMPLANTABLE DEFIBRILLATORS (AVID) COHORT

      Circulation
    13. REITER MJ; REIFFEL JA
      IMPORTANCE OF BETA-BLOCKADE IN THE THERAPY OF SERIOUS VENTRICULAR ARRHYTHMIAS

      The American journal of cardiology
    14. REIFFEL JA; REITER MJ; BLITZER M
      ANTIARRHYTHMIC DRUGS AND DEVICES FOR THE MANAGEMENT OF VENTRICULAR TACHYARRHYTHMIA IN ISCHEMIC-HEART-DISEASE

      The American journal of cardiology
    15. REIFFEL JA; CAMM J
      A SYMPOSIUM - ATRIAL-FIBRILLATION - MECHANISM AND MANAGEMENT - INTRODUCTION

      The American journal of cardiology
    16. PRITCHETT E; KANNEL WB; REIFFEL JA; OLSHANSKY B; LUDERITZ B; REITER M; FALK RH; CAMM J
      EPIDEMIOLOGY AND INCIDENCE OF ATRIAL-FIBRILLATION - DISCUSSION

      The American journal of cardiology
    17. SUNG R; FALK RH; CAMM J; REIFFEL JA; KERR CR; WALDO A; WHARTON M; KAUFMAN E
      ATRIAL-FIBRILLATION - ETIOLOGY, HISTOLOGY AND RISK-FACTORS - DISCUSSION

      The American journal of cardiology
    18. WALDO A; NADEMANEE K; KOWEY PR; REIFFEL JA; FALK RH
      ANTICOAGULATION IN ATRIAL-FIBRILLATION PATIENTS - DISCUSSION

      The American journal of cardiology
    19. SUNG R; GRANT AO; FELD G; REITER M; FRIEDMAN PL; REIFFEL JA; KERR CR; CAMM J
      ELECTROPHYSIOLOGY OF ANTIARRHYTHMIC DRUGS FOR ATRIAL-FIBRILLATION - DISCUSSION

      The American journal of cardiology
    20. REIFFEL JA; REIMOLD SC
      METAANALYSIS OF THE EFFICACY OF PROPAFENONE FOR TREATING SUPRAVENTRICULAR ARRHYTHMIAS - DISCUSSION

      The American journal of cardiology
    21. REIFFEL JA
      SELECTING AN ANTIARRHYTHMIC AGENT FOR ATRIAL-FIBRILLATION SHOULD BE APATIENT-SPECIFIC, DATA-DRIVEN DECISION

      The American journal of cardiology
    22. GRANT AO; REIFFEL JA; WINTERS S; PAGE R; WEBB C; KUTALEK S; NADEMANEE K; OLSHANSKY B; CARLSON M; FERRICK K
      DATA-DRIVEN DECISIONS - PICKING THE CORRECT AGENT - DISCUSSION

      The American journal of cardiology
    23. REIFFEL JA
      IMPACT OF STRUCTURAL HEART-DISEASE ON THE SELECTION OF CLASS-III ANTIARRHYTHMICS FOR THE PREVENTION OF ATRIAL-FIBRILLATION AND FLUTTER

      The American heart journal
    24. REIFFEL JA; HAHN E; HARTZ V
      IS PROCAINAMIDE FAILURE AT ELECTROPHYSIOLOGIC TESTING REALLY AN APPROPRIATE MARKER FOR DRUG-RESISTANT VENTRICULAR TACHYARRHYTHMIAS

      Journal of the American College of Cardiology
    25. REIFFEL JA
      PROLONGING SURVIVAL BY REDUCING ARRHYTHMIC DEATH - PHARMACOLOGICAL THERAPY OF VENTRICULAR-TACHYCARDIA AND FIBRILLATION

      The American journal of cardiology
    26. CURTIS AB; HALLSTROM AP; KLEIN RC; NATH S; PINSKI SL; EPSTEIN AE; WYSE DG; CANNOM DS; RENFROE E; COOPER AS; DAILEY SM; KAY GN; PLUMB VJ; BUBIEN RS; KNOTTS SM; MCKENNA PT; GREER GS; SANTORO IH; SWAIM J; WHITTLE S; BELCO KM; PAYNE JP; ARNOLD DJ; ZHU WX; PRATT CM; COOK JR; KABELL G; KIRCHHOFFER JB; WARWICK D; BURKOTT B; TOMASZEWSKI D; PODRID PJ; FUCHS TT; MAZUR M; FRIEDMAN PL; STEVENSON WG; SWAT MM; GANZ LL; SWEENEY MO; SHEA JB; BRODSKY MA; ALLEN BJ; EHRLICH SS; WOLFF LJ; MACARIHINSON MM; SCHEINMAN M; EISENBERG S; EPSTEIN L; FITZPATRICK A; GRIFFIN G; LEE R; LESH M; WONG MN; WONG M; WILKOFF BL; CROSS JA; SHEWCHIK JM; CARLSON MD; ROSENBAUM DS; LEWIS WR; BIBLO LA; MACKALL JA; WALDO AL; COROMILAS J; BIGGER JT; LIVELLI FD; REIFFEL JA; HICKEY K; BERNS E; LIPPMAN N; BARRY MB; CARNEY HM; RUSSO AM; WAXMAN HL; STUBIN CA; MORRISSEY JM; RASPA DH; CHILSON DA; LESSMEIER TJ; POCHIS WT; BAXTER JM; NADEMANEE K; WEINBERGER J; BAILEY W; REITER M; SAKSENA S; KROL RB; MUNSIF AN; LEWIS CA; LUCERI RM; ZILO P; WEISS DN; JONAS A; VARDEMAN L; SCHWARTZ KM; CURTIS AB; CONTI JB; NELSON C; BHANDARI AK; LERMAN RD; FIRTH BR; ZIPES DP; ENGELSTEIN ED; MILES WM; FOREMAN L; MARTINS JB; LEE HC; HOPSON JR; HOPSON R; MARINCHAK RA; RIALS SJ; KOWEY PR; FILART RA; HERNANDEZ M; SCHER DL; ZUKERMAN LS; FARRELL S; KOLK D; CRINER H; TAIT B; KUTALEK SP; HESSEN SE; MOVSOWITZ C; SAMUELS F; WILBER S; BAESSLER C; SOTO D; SCHUSTER M; SCOTT G; COVELASKYROBINSON R; FLETCHER S; FINN LS; SAARI C; TORRES VI; PAL S; PLATT ML; TIMOTHY PCR; BISHOP VL; LOVE JC; CUTLER JE; BOSWORTHFARRELL S; GOLD MR; SHOROFSKY S; PETERS R; KAVESH N; FROMAN D; SCOTT H; ROTH JA; GADHOKE AM; MAUERMANN SK; PACIFICO A; NASIR N; TRAINOR K; FOSTER P; CREVEY B; GENOVELY H; SCHUTZMAN J; VIATER K; COYLE C; NORA MO; OTOOLE MF; COLLURA R; ENGER EL; ALMQUIST A; BALDWIN P; HAUSER R; MILSTEIN S; PRITZKER M; SCHREIBER V; KIM SG; FISHER JD; FERRICK KJ; GROSS JN; BENZUR U; DURKIN J; FERRICK A; ZEBEDE J; SAMET P; TOLENTINO AO; RUBIN S; HERRE JM; BERNSTEIN RC; KLEVAN LR; JADONATH RL; GOLDNER B; MERKATZ K; CHEPURKO L; BECKMAN KJ; MCCLELLAND JH; GONZALEZ MD; WIDMAN LE; LANE R; MCANULTY JH; HALPERIN BD; KRON J; LARSEN GC; RAITT MH; SWENSON RD; FLOREK RC; MARCHANT C; HAMLIN M; HEYWOOD G; DAUBERT JP; KIM C; SWITZER D; PANDE P; FLYNN D; KELLER M; OCAMPO CM; WAHL K; VOGT J; TULLO NG; IRMIERE CA; HENRY A; STEINBERG JS; EHLERT F; ZELENKOFSKE S; MENCHAVEZTAN E; DESTEFANO M; BROWN G; SUNG RJ; LIEM LB; YOUNG C; LAUER MR; PETERSON J; OTTOBONI L; GOOLD P; ROME M; KRESGE K; BUXTON AE; HSIA HH; MILLER JM; ROTHMAN SA; ADELIZZI N; GASTINEAU ME; THOME LM; WHITLEY DM; SHIH HT; DOUGHERTY AH; JALAL S; NACCARRELLI GV; WOLBRETTE D; WILSON D; PAGE RL; JESSEN M; CANBY RC; ERWIN G; ANDERSON JL; CRANDALL BG; KARAGOUNIS LA; OSBORN JS; RAWLING DA; SUMMERS K; BIGGINS M; FREEDMAN R; MARKS M; CHIEN W; STEVENOT R; MERILLAT J; MCPHERSON M; ECHT DS; RODEN DM; WATHEN MS; LEE JT; MURRAY KT; BAKER JH; CRAWFORD DM; HAINES D; ACKERMAN S; BOWMAN L; STAMATO NJ; WHITING D; JENKINS LS; CONNOLLY S; HALLSTROM AP; GREENE HL; YAO Q; SCHOLZ M; POWELL JL; RENFROE EG; SULLIVAN S; LEDINGHAM RB; MORRIS MF; LANCASTER SE; MOORE R; OLARTE A; SCHRON EB; DOMANSKI MJ; FOLLMANN D; ROSENBERG Y; JENNINGS CA
      INFLUENCE OF PATIENT CHARACTERISTICS IN THE SELECTION OF PATIENTS FORDEFIBRILLATOR IMPLANTATION (THE AVID REGISTRY)

      The American journal of cardiology
    27. REIFFEL JA; HAHN E; HARTZ V; REITER MJ
      SOTALOL FOR VENTRICULAR TACHYARRHYTHMIAS - BETA-BLOCKING AND CLASS-III CONTRIBUTIONS, AND RELATIVE EFFICACY VERSUS CLASS-I DRUGS AFTER PRIOR DRUG FAILURE

      The American journal of cardiology
    28. REITER MJ; KARAGOUNIS LA; MANN DE; REIFFEL JA; HAHN E; HARTZ V
      REPRODUCIBILITY OF DRUG EFFICACY PREDICTIONS BY HOLTER MONITORING IN THE ELECTROPHYSIOLOGIC STUDY VERSUS ELECTROCARDIOGRAPHIC MONITORING (ESVEM) TRIAL

      The American journal of cardiology
    29. MASON JW; MARCUS FI; BIGGER JT; LAZZARA R; REIFFEL JA; REITER MJ; MANN D
      A SUMMARY AND ASSESSMENT OF THE FINDINGS AND CONCLUSIONS OF THE ESVEMTRIAL

      Progress in cardiovascular diseases
    30. REIFFEL JA; REITER MJ; FREEDMAN RA; MANN D; HUANG SKS; HAHN E; HARTZ V; MASON J; MARCUS FI; CARUSO A; FAITELSON HL; RAYA TE; GARCIA Z; GEAR K; PIERCE MK; PRATT CM; BOAHENE A; PACIFICO A; WYNDHAM C; FRANCIS M; KERR CR; YEUNG JA; VORDERBRUGGE S; GRIFFIN JC; LESH M; SCHEINMAN MM; WONG M; WONG M; HEYBORNE T; KENNY C; BIGGER JT; LIVELLI FD; STEINBERG JS; CAMPION J; SQUATRITO AM; MITTLEMAN R; COLLETTWILLEY P; ROFINO K; SAKSENA S; KROL RB; DUQUE L; KLEIN RC; MACHELL C; WIDMAN ML; ACOSTAMILLER C; LOMELI G; KEHOE R; ZHEUTLIN TA; MATTIONI T; DUNNINGTON C; LAZZARA R; BECKMAN K; FRIDAY K; JACKMAN WM; DEATON T; DRENNAN K; FOSTER J; HARRIS S; MCANULTY JH; KRON J; HALPERIN BD; SINNER K; MARTIN K; HOROWITZ LN; GOTTLIEB CD; VRABEL C; MASON JW; ANDERSON JL; ANDERSON KP; KARAGOUNIS L; RAWLING DA; HUTSON H; MANNIS D; ROSKELLEY M; MOON T; RICO A; JENROW N; BRESSLER R; GREENE HL; LEBOWITZ M; MORKIN E; WEAVER WD; BUMP T; MORADY F; OLSHANSKY B
      INFLUENCE OF HOLTER MONITOR AND ELECTROPHYSIOLOGIC STUDY METHODS AND EFFICACY CRITERIA ON THE OUTCOME OF PATIENTS WITH VENTRICULAR-TACHYCARDIA AND VENTRICULAR-FIBRILLATION IN THE ESVEM TRIAL

      Progress in cardiovascular diseases
    31. PRATT CM; GREENWAY PS; SCHOENFELD MH; HIBBEN ML; REIFFEL JA
      EXPLORATION OF THE PRECISION OF CLASSIFYING SUDDEN CARDIAC DEATH - IMPLICATIONS FOR THE INTERPRETATION OF CLINICAL-TRIALS

      Circulation
    32. REIFFEL JA
      IMPLICATIONS OF THE ELECTROPHYSIOLOGIC STUDY VERSUS ELECTROCARDIOGRAPHIC MONITORING TRIAL FOR CONTROLLING VENTRICULAR-TACHYCARDIA AND FIBRILLATION

      The American journal of cardiology
    33. REIFFEL JA; BANKER J
      HOW DO PHYSICIANS DETERMINE WHEN TO PERFORM AN ON-DRUG ELECTROPHYSIOLOGY STUDY FOR EFFICACY DETERMINATION IN PATIENTS WITH SUSTAINED VENTRICULAR TACHYARRHYTHMIAS - A PREVIOUSLY UNADDRESSED VARIABLE THAT MAY AFFECT EFFICACY RATES

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    34. EPSTEIN AE; CONTI JB; CURTIS AB; HESS PG; IANSMITH DH; LOTT JW; MULHOLLAND DH; BUBIEN RS; HAMILTON B; KNOTTS SM; MARDIS M; VINCENT LA; FRIEDMAN PL; STEVENSON W; MARLIN R; SHEA JB; SCHEINMAN M; EISENBERG S; EPSTEIN L; FITZPATRICK A; GRIFFIN G; LEE R; LESH M; WONG MN; WONG M; WILKOFF BL; PINSKI SL; CROSS JA; SCHEWCHIK J; BIGGER JT; COROMILAS J; LIVELLI FD; REIFFEL JA; HICKEY K; NADEMANEE K; WEINBERGER J; BAILEY W; BLANKENSHIP M; SAKSENA S; LEWIS C; WENDLER I; CANNOM D; BHANDARI AK; LERMAN RD; FIRTH BR; ZIPES D; MITRANI R; MILES W; KLEIN L; MARINCHAK R; SCHER DL; ZUKERMAN S; FALCO K; FARRELL S; FISHER B; BRIGGS B; CHIKOWSKI M; CRINER H; KUTALEK S; BAESSLER C; SOTO D; TORRES V; PAI S; TIMOTHY P; BISHOP V; PACIFICO A; NASIR N; RODRIGUEZ I; CALI D; KIM SG; FISHER JD; FERRICK KJ; ROTH JA; GROSS J; MAGNANI M; DURKIN J; FERRICK A; GOMES JA; NELSON S; BECKMAN KJ; LANE R; MCCLELLAND JH; STRAUGHN NG; FOSTER JL; MCANULTY J; FLOREK RC; HALPERIN BD; KRON J; LARSEN GC; SWENSON RD; MARCHANT C; AKIYAMA T; DAUBERT JP; PANDE P; SWITZER D; FLYNN D; OCAMPO C; VOGT J; WAHL K; HERRE JM; LINETTE R; KLEVAN LR; BARACKMAN K; RAYMOND L; SUNG R; LAUER M; LIEM LB; YOUNG C; PETERSON J; OTTOBONI L; STEINBERG J; ZELENKOFSKE S; EHLERT F; TAN EM; WINAND M; CLEVELAND L; BUXTON AE; ADELIZZI N; STEIN D; NACCARRELLI G; DOUGHERTY A; JALAL S; MALONEY J; RIZOPATRON C; SHIH T; ZHU DWX; WILSON D; BELCO K; BERRIER H; POVIA C; ANDERSON JL; CRANDALL BG; KARAGOUNIS LA; OSBORN JS; RAWLING DA; SUMMERS K; BIGGINS M; ECHT D; RODEN D; LEE JT; MURRAY K; WATHEN M; BAKER J; CRAWFORD D; KUDENCHUK P
      ANTIARRHYTHMICS VERSUS IMPLANTABLE DEFIBRILLATORS (AVID) - RATIONALE,DESIGN, AND METHODS

      The American journal of cardiology
    35. LIPKA LJ; DIZON JM; REIFFEL JA
      DESIRED MECHANISMS OF DRUGS FOR VENTRICULAR ARRHYTHMIA - CLASS-III ANTIARRHYTHMIC AGENTS

      The American heart journal
    36. REIFFEL JA; ESTES NAM; WALDO AL; PRYSTOWSKY EN; DIBIANCO R
      A CONSENSUS REPORT ON ANTIARRHYTHMIC DRUG-USE

      Clinical cardiology
    37. REIFFEL JA; KUEHNERT MJ
      ELECTROPHYSIOLOGICAL TESTING OF SINUS NODE FUNCTION - DIAGNOSTIC AND PROGNOSTIC APPLICATION - INCLUDING UPDATED INFORMATION FROM SINUS NODEELECTROGRAMS

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    38. REIFFEL JA; CORREIA J
      IN THE ABSENCE OF STRUCTURAL HEART-DISEASE .... - WHAT IS IT, AND WHYDOES IT MATTER IN ANTIARRHYTHMIC DRUG-THERAPY

      The American heart journal


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/01/21 alle ore 19:39:27